Condition

Glioblastoma Multiforme

ClinicalTrials.gov condition label

Clinical trials19
Recruiting2
Common interventions24
Lead sponsors shown15

Clinical trials

19 shown
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing TumorsNCT06814496 · 2025-09-08
RECRUITING
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsNCT03175224 · 2017-09-27
RECRUITING
Ga-68 Prostate Specific Membrane Antigen PET/CT in GliomasNCT06241391 · 2024-02-01
UNKNOWN
89Zr-girentuximab for PET Imaging of CAIX Positive Solid TumorsNCT05563272 · 2023-06-06
TERMINATED
Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.NCT04712721 · 2021-10-14
TERMINATED
Evaluation of GLR2007 for Advanced Solid TumorsNCT04444427 · 2020-07-15
COMPLETED
A Phase 1-2 Study of ST101 in Patients With Advanced Solid TumorsNCT04478279 · 2020-07-01
ACTIVE_NOT_RECRUITING
18F-PSMA PET/CT for Visualization of Glioblastoma MultiformeNCT04588454 · 2020-01-17
UNKNOWN
The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)NCT03896958 · 2019-03-21
UNKNOWN
A Trial of Ipatasertib in Combination With AtezolizumabNCT03673787 · 2018-08-13
ACTIVE_NOT_RECRUITING
A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced MalignanciesNCT02498665 · 2015-11-01
COMPLETED
A Study Evaluating Safety and Pharmacokinetics of ABBV-221 in Subjects With Advanced Solid Tumor Types Likely to Exhibit Elevated Levels of Epidermal Growth Factor ReceptorNCT02365662 · 2015-01-09
TERMINATED
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic MalignanciesNCT02223052 · 2014-10-27
COMPLETED
Engagement of Patients With Advanced CancerNCT02966509 · 2013-08-01
COMPLETED
BrUOG 263: Prostate Specific Membrane Antigen (PSMA) Glioblastoma Multiforme (GBM)NCT01856933 · 2013-05-01
COMPLETED
Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial CancerNCT01631552 · 2012-12-17
COMPLETED
Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer SurvivorsNCT01929720 · 2011-08-01
COMPLETED
Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.NCT01353625 · 2011-04-25
COMPLETED
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple MyelomaNCT01177397 · 2010-07-20
COMPLETED

Common interventions

18F-PSMA-1007 PET tracerOTHER168Ga-FF58DRUG189Zr-girentuximab for PET/CT imaging of CAIX positive tumorsDIAGNOSTIC_TEST1ABBV-221DRUG1APL-101 Oral CapsulesDRUG1AtezolizumabDRUG1CC-115DRUG1CC-223DRUG1CC-486DRUG1Cognitive-behavioral therapy for worry, uncertainty & insomniaBEHAVIORAL1Concurrent Radiation TherapyRADIATION1DSP-7888 Dosing EmulsionDRUG1EPACBEHAVIORAL1GLR2007DRUG1ipatasertibDRUG1PSMA ADCDRUG1PSMA PET-CTDIAGNOSTIC_TEST1RadiationRADIATION1Sacituzumab Govitecan-hziy (SG)DRUG1Sequential Radiation therapyRADIATION1ST101DRUG1TarlatamabDRUG1TemozolomideDRUG1VidazaDRUG1

Trial status mix

COMPLETED9
TERMINATED3
UNKNOWN3
ACTIVE_NOT_RECRUITING2
RECRUITING2

Phase mix

PHASE110
PHASE29
NA4
EARLY_PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.